News

Verano Holdings Reports 2024 Q4 & Annual Financial Performances

Verano Holdings Reports 2024 Q4 & Annual Financial Performances

Financial Results Overview for Verano Holdings

Verano Holdings Corp. (Cboe CA: VRNO) (OTCQX: VRNOF), a prominent player in the cannabis industry, has successfully published its financial results for the fourth quarter and entire year of 2024. These results underline the company's commitment to growth and innovation in a rapidly changing industry.

Quarterly and Yearly Financial Highlights

Fourth Quarter Financial Highlights

  • Quarterly revenues report net of discounts reached $218 million, indicating an 8% decrease year-over-year but a slight increase of 1% compared to the previous quarter.
  • Gross profit amounted to $108 million, marking 49% of total revenue.
  • Sales, General, and Administrative (SG&A) expenses were reported at $84 million, which is 38% of revenue.
  • The net loss for this period stood at $273 million or 125% of revenue.
  • Adjusted EBITDA was recorded at $63 million, representing 29% of revenue.
  • The company generated $44 million in cash from operating activities during the quarter.
  • Capital expenditures totaled $14 million.

Annual Financial Overview

  • For the year, net revenues tallied up to $879 million, which was a 6% decline compared to the previous year.
  • Gross profit for the year was $444 million or 51% of revenue.
  • SG&A expenses totaled $353 million, which accounted for 40% of total revenue.
  • The company's net loss was $342 million, equating to 39% of revenue.
  • Adjusted EBITDA for the year came in at $264 million or 30% of revenues.
  • Operating activities produced a net cash inflow of $112 million for the year.
  • Capital expenditures amounted to $99 million.

Insights from Management

George Archos, founder and CEO of Verano, expressed profound pride in the team's resilience throughout 2024, which laid a strong foundation to enhance core business operations and pursue future growth. "In a dynamic context, we have successfully established our presence in new markets, including Virginia, and ramped up operations in existing regions like Arizona," Archos added.

Strategies for Continued Growth

Looking forward, Verano is focused on harnessing innovation and operational excellence. Archos emphasizes the importance of speed and adaptability in the mission to grow Verano into a leading cannabis enterprise that prioritizes quality and customer satisfaction. This focus spans across various sectors of the business, ensuring robust offerings that cater to consumer demands.

Fourth Quarter Financial Breakdown

Delving deeper into Q4, the reported revenue reflects fluctuations driven by price pressures and promotional activities in key markets. The gross profit holds significant value at 49% of revenue, yet shows a dip from previous periods primarily due to revenue contraction. Verano has optimized its operating expenses effectively, reducing SG&A through strategic operational efficiencies.

Financial Guidance for 2025

  • Verano anticipates capital expenditures ranging from $25 to $40 million in 2025, reflecting a cautious yet optimistic approach towards expansion and market penetration.

Operational Achievements in Q4

  • Launched the "Save the BITS" campaign, uniting dispensaries across states to support breast cancer research.
  • Initiated adult use sales at Zen Leaf Waterbury, converting existing dispensaries into a dual sales model.
  • Broadened operational reach with new dispensary openings, elevating the brand's footprint in New Jersey.
  • Responded positively to consumer trends by introducing innovative products across fast-growing categories.

Subsequent Developments

  • In January, Verano strategically terminated certain retail agreements and successfully sold specific leased properties.
  • The company has continued to expand its presence, with new openings in Florida enhancing their operational capacity and retail presence.
  • Active operations now span 13 states, maintaining a comprehensive network of 153 dispensaries and 15 production facilities.

Current Financial Health

As of year-end 2024, Verano's balance sheet shows strong liquidity with $358 million in current assets, including $88 million in cash. A working capital of $160 million indicates robust financial health, while total debts sum up to $414 million.

Engagement with Stakeholders

A conference call is scheduled to delve further into these results, allowing analysts and investors a chance to engage with the Verano leadership to discuss strategies and outlook.

Frequently Asked Questions

What financial results did Verano report for Q4 2024?

Verano reported revenues of $218 million with a net loss of $273 million in Q4 2024.

What are the significant changes in Verano's annual financial highlights?

Overall revenue for 2024 was $879 million, down 6% from the previous year, with gross profit at 51% of revenue.

What strategies is Verano adopting for future growth?

Verano aims to leverage innovation and automation to enhance growth and adapt to consumer demands in the cannabis sector.

What operational achievements did Verano realize in Q4 2024?

Verano launched new retail operations, entered new markets, and introduced several innovative products based on market trends.

What financial guidance has Verano provided for 2025?

Verano anticipates capital expenditures between $25 and $40 million for 2025.

About The Author

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.

Top 10 Most Recent News Articles

Black Friday Doubt Grows: Just 54% Trust Real Deals

Updated Category News Views 93

Do Shoppers Believe in Black Friday Anymore? You'd think by now, retailers would have cracked the code on building trust with their customers. But guess what? A fresh survey from Boston Consulting Group reveals only 54% of consumers buy the whole Black Friday discount story. That's barely more than flipping a coin. Promotion Fatigue: The Trust Buster Funny thing,...

Continue Reading
CStone, Kimia Collaboration Targets Solid Tumor Survival

Updated Category News Views 106

Biotech Giants CStone and Kimia Unite Forces In the heart of China's biotechnology scene, the latest collaboration news to hit the wires is CStone Pharmaceuticals shaking hands with Kimia Therapeutics. Now, don't go tossing this aside as another run-of-the-mill partnership announcement. CStone's HKEX: 2616 ticker has got its eyes locked on an ambitious dance with Kimia,...

Continue Reading
Samsung Biologics Hits 'Negligible' ESG Risk Milestone

Updated Category News Views 60

Samsung Biologics Achieves a Low-Risk Triumph You gotta hand it to Samsung Biologics for hitting a 'Negligible Risk' rating. Their latest score? A cool 9.0. That’s like walking into the pharmaceuticals room and getting a standing ovation. It's no small feat—climbing up from a 'Low Risk' rating to the top tier in Morningstar Sustainalytics' playbook. For us spectating...

Continue Reading
Emergency Surgery Verification Lowers Death Rates: Study

Updated Category News Views 37

Diving into Emergency General Surgery Verification How often do you hear a hospital accreditation making a real difference? The latest report in JAMA Surgery suggests it’s more than just a plaque on the wall for some. We're talking about the American College of Surgeons (ACS) Emergency General Surgery Verification program, which links directly to better patient...

Continue Reading
Stellus Capital Set to Unveil Q3 Results: Key Details

Updated Category News Views 92

Stellus Capital's Upcoming Financial Reveal: Stakes and Details November's not just bringing the cold breezes, folks; it's also ushering in the much-anticipated financial digits of Stellus Capital Investment Corporation's third quarter of 2026. Mark your calendars for November 9, after the stock market wraps up, when Stellus will drop its operational performance stats for...

Continue Reading
Life with PAH: A Journey of Awareness and Hope

Updated Category News Views 224

Unearthing the Hidden Struggle of PAH The American Lung Association (ALA) is getting loud about a quiet killer—pulmonary arterial hypertension (PAH) is in their spotlight this month, and it's about time. Documenting the horror stories of some 500 to 1,000 new PAH diagnoses each year in the U.S., the ALA is peeling back the blinds on a condition that's too often...

Continue Reading
KFC Teams with Marvel for Record-Breaking Menu Launch

Updated Category News Views 124

Movie Magic on the Menu When was the last time a bucket of fried chicken sent such ripple effects through pop culture? KFC's decision to sling Doctor Doom-inspired dishes across 100 countries smells like genius business mixed with a dash of the absurd. Just imagine: an empire of battered birds aligning with Marvel's latest cinematic heavy hitter, "Avengers: Doomsday." Now...

Continue Reading
AppLovin Faces Lawsuit: Investor Unrest Unfolds

Updated Category News Views 160

Shaky Ground Beneath AppLovin's Feet Ah, the sweet smell of litigation in the tech space—it’s like déjà vu for seasoned market folks. Here we have AppLovin, nestled comfortably in San Francisco, now eying a saucy class-action lawsuit. We're looking at shareholders taking a firm stance against some arguably misleading claims. We're talking big deals with allegations...

Continue Reading
Singtel, Ericsson Push 6G Healthcare to the Forefront

Updated Category News Views 83

Breaking Ground in Healthcare Tech Ah, what’s cooking in Singapore? On a day like today, when the tech giants Singtel and Ericsson get chummy with National University Health System (NUHS), we're looking at the kind of healthcare advancements that read like science fiction. They’ve signed an MOU to launch the National University XG AI Centre (NXAC) – a mouthful,...

Continue Reading
Lakefront Living: Steuben County's Twin Tales

Updated Category News Views 22

Here’s how it is: choosing a lakefront home in Steuben County, Indiana, ain't just about picking a place with a killer view. It’s like buying a lifestyle package and you’d better know what you’re getting. An article by Tony Isa, the go-to real estate guru in these parts, puts the spotlight on Lake James and Clear Lake—but what matters is how each might wrangle...

Continue Reading

Top 5 Most Recently Viewed Articles

Recent Insider Trading Insights on Teva Pharmaceutical Stock

Updated Category News Views 155

Recent Insider Trading at Teva Pharmaceutical Industries A notable insider transaction occurred recently, with Amir Weiss, the Chief Accounting Officer at Teva Pharmaceutical Industries Ltd (NYSE: TEVA), unloading shares worth $300,564 as reported by a recent SEC filing. Details of the Transaction According to the Form 4 filing submitted to the U.S. Securities and...

Continue Reading
TIER IV and Newmo Join Forces for Innovative Robotaxi Services

Updated Category News Views 266

Transforming Mobility with Robotaxi Services TIER IV, renowned for developing the first open-source software for autonomous driving, has teamed up with mobility startup Newmo to revolutionize transportation services. This partnership marks a significant step toward the commercialization of robotaxi services, offering solutions tailored for local communities. Your Solution...

Continue Reading
Investors of Wolfspeed Inc. Face Deadline for Class Action Claims

Updated Category News Views 262

Investors Urged to Take Action After Stock Price Drop Recent developments surrounding Wolfspeed, Inc. have raised significant concerns among investors, especially following the staggering drop in the company's stock price. Those who invested in Wolfspeed, often identified by its ticker WOLF, may now find themselves questioning their portfolio decisions. Amidst this...

Continue Reading
Team Falcons Triumphs at Esports World Cup 2025 Championship

Updated Category News Views 261

Team Falcons' Incredible Journey to Victory The culmination of the Esports World Cup 2025 showcased an exhilarating journey for Team Falcons, who emerged as the dominant force in this prestigious multi-title esports tournament. Over seven weeks, the tournament attracted a staggering 750 million viewers worldwide and recorded 350 million hours of online watch time. These...

Continue Reading
GENFIT's 2024 Registration Document and Annual Report Release

Updated Category News Views 224

GENFIT Files 2024 Universal Registration Document Lille, France - GENFIT (Nasdaq and Euronext: GNFT), a pioneering biopharmaceutical firm dedicated to the welfare of patients suffering from rare and life-threatening liver conditions, has achieved a significant milestone by filing its 2024 Universal Registration Document alongside its Annual Report on Form 20-F with...

Continue Reading